Ege David S.

Insider profile

Ege David S.'s trades of Seres Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-08-19 2024-08-16 PlS Planned sale
43,369 +18.7%
446.18
US$2,722,965
43,369 +18.7% 446.18 US$2,722,965
2024-05-17 2024-05-15 PlS Planned sale
81,141 -46.9%
344.30
US$527,637
81,141 -46.9% 344.30 US$527,637
2024-02-16 2024-02-16 PlS Planned sale
68,233 +5.3%
468.30
US$1,496,909
68,233 +5.3% 468.30 US$1,496,909
2023-10-31 2023-10-30 PlS Planned sale
4,066 -5.7%
1.35
US$5,489
4,066 -5.7% 1.35 US$5,489
2023-05-01 2023-04-28 PlS Planned sale
7,038 -10.5%
5.19
US$36,527
7,038 -10.5% 5.19 US$36,527
2022-10-31 2022-10-31 PlS Planned sale
5,012 -9.7%
7.93
US$39,745
5,012 -9.7% 7.93 US$39,745